Why is the cannabis that you have in laboratory called medical?
When discussing medical cannabis, it’s crucial to consider the nature of the patients who utilize it as therapy. Typically, we’re referring to individuals who are particularly fragile or ill, often with compromised immune systems. Therefore, it’s imperative that they receive a therapy that is completely sterile and safe. We label it “medical cannabis” because it’s […]
Legislative Panorama: Focus On Denmark
Denmark has a relatively small cannabis market compared to other European countries, primarily due to strict regulations and high prices in its medical cannabis program. These factors have limited the program’s success thus far. Medical cannabis is legal in Denmark, and patients have several options to access it. Authorized medicines like Sativex and Epidiolex, which […]
Will Medical Cannabis Redefine Breast Cancer Care for Patients in the US?
Although federal laws governing the use of cannabis in the United States have remained rigid for decades, state laws have, to some extent, evolved in the last 27 years to allow limited use of cannabis for medical purposes. This began with Proposition 215, or the Compassionate Use Act of 1996, in California. Since then, several […]
Israeli Health Ministry Unveils Vital Medical Cannabis Reforms to Enhance Patient Access
The Israeli Health Ministry announced the eagerly awaited medical cannabis reforms in a statement published on the 7th of August 2023 by the ministry’s Economics, Regulation, and Innovation Directorate. The new reforms are most certainly going to result in an uptick in the consumption of medical cannabis by patients, as treatment will be easier to […]
Legislative Panorama: Focus On Netherlands
Abstract Access to medical cannabis in the Netherlands has been limited, despite its availability as a prescription drug since 2003. The National Health Institute’s reluctance to officially recognize medical cannabis as a treatment has resulted in increased costs through official channels. Consequently, there has been a significant decline in medical cannabis prescriptions, and the number […]
Legislative Panorama: Focus On Portugal
Since 2018, medical cannabis has been legal in Portugal, but only one pharmaceutical company, Tilray, has been approved by Infarmed, the regulatory agency responsible for approving medical cannabis products in the country. Medical cannabis use in Portugal is limited to cases where conventional treatments are ineffective or cause adverse effects, and the therapeutic indication has […]
Legislative Panorama: Focus On Switzerland
Switzerland’s CBD and medical cannabis industry is currently valued at an estimated EUR 75 million, a figure expected to more than double as regulated medical and adult-use cannabis consumption picks up. Since August 2022, Swiss physicians can prescribe medical cannabis to patients without limitations. Switzerland’s move toward making adult-use and medical-use cannabis accessible is likely […]
March is Endometriosis Awareness Month!
Every March, the world observes Endometriosis Awareness Month to raise awareness and support millions of women affected by Endometriosis around the globe. Endometriosis impacts the lives of hundreds of women living with the condition, disrupting their lives as they endure unbearable pain among a plethora of symptoms that significantly degrade their quality of life. Women […]
GQC – Global Quality Cannabis – the new Start-up to support the Medical Cannabis Industry
PQE Group is pleased to announce the launch of GQC – Glocal Quality Cannabis. The newly created company is the world’s first start-up to support pharmaceutical companies in every aspect of medical cannabis development and distribution. GQC is part of the PQE Group federation, a world leading quality solution provider for the Life Science industry […]
